Mezzion Pharma Co., Ltd. Stock Price & Chart

KRX: 140410 · 메지온 · KOSPI

₩60,600▲ ₩6,700 (+12.43%)at close · July 27, 2026
179,90035,85060,600Jul 03, 25Oct 10Jan 14Apr 20Jul 27, 26

Mezzion Pharma Co., Ltd. (메지온, KRX: 140410) last closed at ₩60,600 on July 27, 2026, a +12.43% move on the day. Over the trailing 52 weeks the stock has traded between ₩35,850 and ₩179,900, a +63.56% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩60,600
Day change+12.43%
52-week high₩179,900
52-week low₩35,850

Key Fundamentals

FY 2026.03
Market cap₩1.85T
P/E (PER)-46.47
P/B (PBR)107.07
EPS₩-1,160
BPS₩566
ROE-125.67%
Debt ratio537.76%
Rev. growth3.19%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-27
Weak BearishAlgorithmic summary of 5 standard indicators (net score -1). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 56,335
  • ▼ Bearish60-day MAPrice below 65,800
  • ▼ Bearish120-day MAPrice below 90,191
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 51 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 17% of rangeRSI(14): 515-day volume vs 20-day: +3%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning Mezzion Pharma Co., Ltd.

No daily reports have covered Mezzion Pharma Co., Ltd. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.